Abstract

Metabolic engineering is a powerful tool which has been widely used for producing valuable products. For improving l-phenylalanine (l-Phe) accumulation in Corynebacterium glutamicum, we have investigated the target genes involved in the biosynthetic pathways. The genes involved in the biosynthesis of l-Phe were found to be strictly regulated genes by feedback inhibition. As a result, overexpression of the native wild-type genes aroF, aroG or pheA resulted in a slight increase of l-Phe. In contrast, overexpression of aroFwt or pheAfbr from E. coli significantly increased l-Phe production. Co-overexpression of aroFwt and pheAfbr improved the titer of l-Phe to 4.46 ± 0.06 g l−1. To further analyze the target enzymes in the aromatic amino acid synthesis pathway between C. glutamicum and E. coli, the wild-type gene aroH from E. coli was overexpressed and evaluated in C. glutamicum. As predicted, upregulation of the wild-type gene aroH resulted in a remarkable increase of l-Phe production. Co-overexpression of the mutated pheAfbr and the wild-type gene aroH resulted in the production of l-Phe up to 4.64 ± 0.09 g l−1. Based on these results we conclude that the wild-type gene aroH from E. coli is an appropriate target gene for pathway engineering in C. glutamicum for the production of aromatic amino acids.

Introduction

l-phenylalanine (l-Phe), one of the essential amino acids for humans and other animals, is widely used in food and pharmaceutical industries [1, 29, 33]. In early industrial processes l-Phe was mainly produced by chemical synthesis. However, because of the very specific demand for the stereo-specific form, consumer’s preference, and various problems with chemical synthesis, the latter is gradually being replaced with bioprocessing, such as microbial fermentation and enzymatic transformation [22]. More recently, metabolic engineering has focused on the Gram-negative strain Escherichia coli and many other well-characterized model microorganisms, and cell factories have been constructed [13, 24, 33]. Although high titers of l-Phe can be produced, the industrial-scale production of l-Phe by genetically engineered E. coli has encountered a lot of problems, especially infection by phage. This has led to the search for alternative robust engineered strains (e.g. Corynebacterium glutamicum).

Since 1957, C. glutamicum, a well-known Gram-positive strain in industrial processes, has been widely used for producing amino acids, especially l-glutamate and l-lysine [9, 26]. The whole genome sequencing of C. glutamicum has led to the successful development of many sophisticated vectors which have been applied in C. glutamicum [6, 18, 23, 30]. In recent years, researchers have taken advantage of the powerful toolbox that has become available (“omics” technologies, metabolic pathway engineering, targeted enzyme modification) and successfully engineered C. glutamicum for producing many high valuable-added products, as described in the excellent review by Becker and Wittmann [2]. Due to the attractive features of genetically engineered C. glutamicum, such as fast growth rate, lack of endotoxin and protease secretion and easy purification step [6], C. glutamicum has also been used for the heterologous expression of recombinant proteins [3, 4, 20]. In addition, C. glutamicum has a distinct ability to simultaneously metabolize pentose and hexose, which makes this microorganism a potential candidate for transforming renewable biomasses to value-added products [9].

C. glutamicum’s l-Phe biosynthesis pathway, similar to that E. coli, is divided into three parts: central carbon metabolism, the shikimate pathway and the chorismate pathway [15]. Much research has focused on elucidating this pathway in E. coli, and the enzyme 3-deoxy-7-phosphoheptulonate synthase (DS, encoded by aroG, aroF and aroH) and the bifunctional enzyme chorismate mutase-p-prephenate dehydratase (CM-PDT, encoded by pheA) have been identified as the committed enzymes [7, 14, 25]. In E. coli, the three DS isozymes encoded by aroG, aroF and aroH are feedback inhibited by l-Phe, l-tyrosine (l-Tyr) and l-tryptophan (l-Trp), respectively (Fig. 1a) [10, 13, 27]. In C. glutamicum, the two DS isozymes, which are encoded by aroG and aroF, are feedback inhibited by l-Phe, chorismate and prephenate and by l-Tyr and l-Tyr, respectively (Fig. 1b) [6, 21, 27]. Nevertheless, in E. coli, the bifunctional enzyme CM-PDT is feedback inhibited by l-Phe and l-Tyr. In C. glutamicum, the enzymes CM and prephenate dehydratase (PD) are encoded by csm [21] and pheA [16], respectively. Further studies have demonstrated that CM activity is not affected by l-Phe, l-Tyr or l-Trp [21] while PD activity is feedback inhibited by l-Phe [6, 12].
Fig. 1

l-phenylalanine (l-Phe) biosynthesis pathway in Escherichia coli (a) and Corynebacterium glutamicum (b). Dotted lines, dashed lines feedback inhibition and repression, respectively. DS 3-deoxy-D-arabinoheptulosonate 7-phosphate synthase, CM chorismate mutase, PD prephenate dehydratase, CDRP 1-(2-carboxyphenylamino)-1-deoxy-D-nbulose-5-phosphate, I3GP indole 3-glycerolphosphate, PRAA n-(5-phospho-β-D-nbosylanthranilate), PRT anthranilate phosphoribosyltransferase

To accumulate l-Phe efficiently in E. coli, the aroG and pheA genes from E. coli were modified by site-mutation to eliminate the specific feedback inhibition and overexpressed to increase the production of l-Phe [1, 8, 31, 33]. In a similar approach, the mutated pheA gene of E. coli was introduced into C. glutamicum KY10694, and a 30 % increase of l-Phe was achieved [17]. In one study, integration of the aroG-pheA tandem genes of E. coli into C. glutamicum resulted in a 1.71-fold increase in l-Phe production, although the highest concentration was also very low (3.97 g l−1) in shake flask cultivation [22]. Shu et al. [24] achieved a high level of l-Phe (23.2 g l−1) by supplying elevated oxygen into 5-l fermentor with the wild-type strain. In a previous study in E. coli in which we analyzed the key enzymes of the shikimate and chorismate pathways in C. glutamicum ATCC 13032, we found that the wild-type gene aroH that is inhibited by l-Trp from E. coli was expressed in C. glutamicum and contributed significantly to increased l-Phe production. By co-overexpression of mutated pheA and the wild-type aroH gene, l-Phe was increased by 13.6-fold. In addition, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and reverse transcription (RT) PCR data showed that the levels of the mutated pheA and wild-type aroH within one operon were significantly different, suggesting that precise regulation of the target enzymes might be beneficial to the titer of the target end-product, l-Phe.

Materials and methods

Bacterial strains and plasmids

Bacterial strains, plasmids and oligonucleotides used in this study are listed in Tables 1 and 2. E. coli JM109 was applied for molecular cloning and manipulation of plasmids. C. glutamicum ATCC 13032 as the parent strain was engineered for producing l-Phe. Genes aroG, aroF and pheA were amplified from genomic DNA of C. glutamicum ATCC 13032 while the wild-type gene aroH was amplified from genomic DNA of E. coli W3110. After digestion, the fragments were subcloned into pXMJ19 to generate pXMJ19-aroG, pXMJ19-aroF, pXMJ19-pheA and pXMJ19-aroH, respectively. PheAfbr and aroFwt were amplified from plasmid pAP-B03 [33] and subcloned into pXMJ19, resulting in plasmids pXMJ19-pheAfbr and pXMJ19-aroFwt, respectively. To increase the translation efficiency, the Shine-Dalgarno sequence (AGGAGGA) was artificially added in the upstream of starting codon ATG (Table 1).

Strains and plasmids used in this study

Strains and plasmidsRelevant propertiesSource or reference
Strains
 Escherichia coli JM109Wide-type E. coli.Lab stock
 E. coli W3110In(rrnD-rrnE) E. coliLab stock
 Corynebacterium glutamicum ATCC 13032Wide-type C. glutamicumATCC
 C. glutamicum 19GC. glutamicum ATCC 13032 harboring pXMJ19- aroGThis work
 C. glutamicum 19FC. glutamicum ATCC 13032 harboring pXMJ19- aroFThis work
 C. glutamicum 19FwtC. glutamicum ATCC 13032 harboring pXMJ19- aroFwtThis work
 C. glutamicum 19HC. glutamicum ATCC 13032 harboring pXMJ19- aroHThis work
 C. glutamicum 19AC. glutamicum ATCC 13032 harboring pXMJ19-pheAThis work
 C. glutamicum 19AfbrC. glutamicum ATCC 13032 harboring pXMJ19-pheAfbrThis work
 C. glutamicum 19AfbrHC. glutamicum ATCC 13032 harboring pXMJ19-pheAfbr-aroHThis work
 C. glutamicum 19AfbrFwtC. glutamicum ATCC 13032 harboring pXMJ19-pheAfbr-aroFwtThis work
Plasmids
 pMD19-simple VectorCloning vector, AmpRTakara, Dalian, China
 pXMJ19E. coli-C. glutamicum shuttle expression vector[6]
 pAP-B03Derivative from pACYC177 and pPL450, containing pheAfbr and aroFwt[33]
 pXMJ19-aroGpXMJ19 containing aroG (C. glutamicum ATCC 13032)This work
 pXMJ19-aroFpXMJ19 containing aroF gene (C. glutamicum ATCC 13032)This work
 pXMJ19-aroFwtpXMJ19 containing aroFwt gene (pAP-B03)This work
 pXMJ19-aroHpXMJ19 containing aroH (E. coli 3110)This work
 pXMJ19-pheApXMJ19 containing pheA (C. glutamicum ATCC 13032)This work
 pXMJ19-pheAfbrpXMJ19 containing pheAfbr (pAP-B03)This work
 pXMJ19-pheAfbr-aroHpXMJ19 containing pheAfbr (pAP-B03) and aroH (E. coli)This work
 pXMJ19-pheAfbr-aroFwtpXMJ19 containing pheAfbr (pAP-B03) and aroFwt (pAP-B03)This work
Strains and plasmidsRelevant propertiesSource or reference
Strains
 Escherichia coli JM109Wide-type E. coli.Lab stock
 E. coli W3110In(rrnD-rrnE) E. coliLab stock
 Corynebacterium glutamicum ATCC 13032Wide-type C. glutamicumATCC
 C. glutamicum 19GC. glutamicum ATCC 13032 harboring pXMJ19- aroGThis work
 C. glutamicum 19FC. glutamicum ATCC 13032 harboring pXMJ19- aroFThis work
 C. glutamicum 19FwtC. glutamicum ATCC 13032 harboring pXMJ19- aroFwtThis work
 C. glutamicum 19HC. glutamicum ATCC 13032 harboring pXMJ19- aroHThis work
 C. glutamicum 19AC. glutamicum ATCC 13032 harboring pXMJ19-pheAThis work
 C. glutamicum 19AfbrC. glutamicum ATCC 13032 harboring pXMJ19-pheAfbrThis work
 C. glutamicum 19AfbrHC. glutamicum ATCC 13032 harboring pXMJ19-pheAfbr-aroHThis work
 C. glutamicum 19AfbrFwtC. glutamicum ATCC 13032 harboring pXMJ19-pheAfbr-aroFwtThis work
Plasmids
 pMD19-simple VectorCloning vector, AmpRTakara, Dalian, China
 pXMJ19E. coli-C. glutamicum shuttle expression vector[6]
 pAP-B03Derivative from pACYC177 and pPL450, containing pheAfbr and aroFwt[33]
 pXMJ19-aroGpXMJ19 containing aroG (C. glutamicum ATCC 13032)This work
 pXMJ19-aroFpXMJ19 containing aroF gene (C. glutamicum ATCC 13032)This work
 pXMJ19-aroFwtpXMJ19 containing aroFwt gene (pAP-B03)This work
 pXMJ19-aroHpXMJ19 containing aroH (E. coli 3110)This work
 pXMJ19-pheApXMJ19 containing pheA (C. glutamicum ATCC 13032)This work
 pXMJ19-pheAfbrpXMJ19 containing pheAfbr (pAP-B03)This work
 pXMJ19-pheAfbr-aroHpXMJ19 containing pheAfbr (pAP-B03) and aroH (E. coli)This work
 pXMJ19-pheAfbr-aroFwtpXMJ19 containing pheAfbr (pAP-B03) and aroFwt (pAP-B03)This work

ATCC  American type culture collection

Strains and plasmids used in this study

Strains and plasmidsRelevant propertiesSource or reference
Strains
 Escherichia coli JM109Wide-type E. coli.Lab stock
 E. coli W3110In(rrnD-rrnE) E. coliLab stock
 Corynebacterium glutamicum ATCC 13032Wide-type C. glutamicumATCC
 C. glutamicum 19GC. glutamicum ATCC 13032 harboring pXMJ19- aroGThis work
 C. glutamicum 19FC. glutamicum ATCC 13032 harboring pXMJ19- aroFThis work
 C. glutamicum 19FwtC. glutamicum ATCC 13032 harboring pXMJ19- aroFwtThis work
 C. glutamicum 19HC. glutamicum ATCC 13032 harboring pXMJ19- aroHThis work
 C. glutamicum 19AC. glutamicum ATCC 13032 harboring pXMJ19-pheAThis work
 C. glutamicum 19AfbrC. glutamicum ATCC 13032 harboring pXMJ19-pheAfbrThis work
 C. glutamicum 19AfbrHC. glutamicum ATCC 13032 harboring pXMJ19-pheAfbr-aroHThis work
 C. glutamicum 19AfbrFwtC. glutamicum ATCC 13032 harboring pXMJ19-pheAfbr-aroFwtThis work
Plasmids
 pMD19-simple VectorCloning vector, AmpRTakara, Dalian, China
 pXMJ19E. coli-C. glutamicum shuttle expression vector[6]
 pAP-B03Derivative from pACYC177 and pPL450, containing pheAfbr and aroFwt[33]
 pXMJ19-aroGpXMJ19 containing aroG (C. glutamicum ATCC 13032)This work
 pXMJ19-aroFpXMJ19 containing aroF gene (C. glutamicum ATCC 13032)This work
 pXMJ19-aroFwtpXMJ19 containing aroFwt gene (pAP-B03)This work
 pXMJ19-aroHpXMJ19 containing aroH (E. coli 3110)This work
 pXMJ19-pheApXMJ19 containing pheA (C. glutamicum ATCC 13032)This work
 pXMJ19-pheAfbrpXMJ19 containing pheAfbr (pAP-B03)This work
 pXMJ19-pheAfbr-aroHpXMJ19 containing pheAfbr (pAP-B03) and aroH (E. coli)This work
 pXMJ19-pheAfbr-aroFwtpXMJ19 containing pheAfbr (pAP-B03) and aroFwt (pAP-B03)This work
Strains and plasmidsRelevant propertiesSource or reference
Strains
 Escherichia coli JM109Wide-type E. coli.Lab stock
 E. coli W3110In(rrnD-rrnE) E. coliLab stock
 Corynebacterium glutamicum ATCC 13032Wide-type C. glutamicumATCC
 C. glutamicum 19GC. glutamicum ATCC 13032 harboring pXMJ19- aroGThis work
 C. glutamicum 19FC. glutamicum ATCC 13032 harboring pXMJ19- aroFThis work
 C. glutamicum 19FwtC. glutamicum ATCC 13032 harboring pXMJ19- aroFwtThis work
 C. glutamicum 19HC. glutamicum ATCC 13032 harboring pXMJ19- aroHThis work
 C. glutamicum 19AC. glutamicum ATCC 13032 harboring pXMJ19-pheAThis work
 C. glutamicum 19AfbrC. glutamicum ATCC 13032 harboring pXMJ19-pheAfbrThis work
 C. glutamicum 19AfbrHC. glutamicum ATCC 13032 harboring pXMJ19-pheAfbr-aroHThis work
 C. glutamicum 19AfbrFwtC. glutamicum ATCC 13032 harboring pXMJ19-pheAfbr-aroFwtThis work
Plasmids
 pMD19-simple VectorCloning vector, AmpRTakara, Dalian, China
 pXMJ19E. coli-C. glutamicum shuttle expression vector[6]
 pAP-B03Derivative from pACYC177 and pPL450, containing pheAfbr and aroFwt[33]
 pXMJ19-aroGpXMJ19 containing aroG (C. glutamicum ATCC 13032)This work
 pXMJ19-aroFpXMJ19 containing aroF gene (C. glutamicum ATCC 13032)This work
 pXMJ19-aroFwtpXMJ19 containing aroFwt gene (pAP-B03)This work
 pXMJ19-aroHpXMJ19 containing aroH (E. coli 3110)This work
 pXMJ19-pheApXMJ19 containing pheA (C. glutamicum ATCC 13032)This work
 pXMJ19-pheAfbrpXMJ19 containing pheAfbr (pAP-B03)This work
 pXMJ19-pheAfbr-aroHpXMJ19 containing pheAfbr (pAP-B03) and aroH (E. coli)This work
 pXMJ19-pheAfbr-aroFwtpXMJ19 containing pheAfbr (pAP-B03) and aroFwt (pAP-B03)This work

ATCC  American type culture collection

 

Primers used in this study

Primers and reverse transcription primersSequencea
Primers
 aroG-F5′-CTAGTCTAGAAAAGGAGGACACGCATGAGTTCTCCAGTCTCACTCGAAAA-3′
 aroG-R5′-TCCCCCGGGTTACTTGGCTGCTGCTCGGC-3′
 aroF-F5′-CCCAAGCTTAAAGGAGGACACGCATGAGTTCTCCAGTCTCACTCGAAAA-3′
 aroF-R5′-CGCGGATCCTTACTTGGCTGCTGCTCGGC-3′
 aroFwt-F5′-TCCCCGCGGAAAGGAGGACACGCATGCAAAAAGACGCGCTGAATAACG-3′
 aroFwt-R5′-CGCGGATCCCCGCTCGAGTTAAGCCACGCGAGCCGTCA-3′
 aroH-F5′-CGCGGATCCAAAGGAGGACACGCATGAACAGAACTGACGAACTCCGTAC-3′
 aroH-R5′-TCCCCCGGGCCGCTCGAGTCAGAAGCGGGTATCTACCGCA-3′
 pheA-F5′-CCCAAGCTTAAAGGAGGACACGC ATGAGCGACGCACCAACTGTTG-3′
 pheA-R5′-TCCCCCGGG CTAGTTAAGTTTCCTTCCTTCGCTTGCT-3′
 pheAfbr-F5′-CCCAAGCTTAAAGGAGGACACGCATGACATCGGAAAACCCGTTACT-3′
 pheAfbr-R5′-TGCACTGCAGTCCCCGCGGTCAGGTTGGATCAACAGGCACTA-3′
Primers for RT-PCR
 aroH_F5′-ACTGACGAACTCCGTACTGC-3′
 aroH_R5′-TCGCTTATCTTCACCATTCA-3′
 aroFwt_F5′-AGACGCGCTGAATAACGTAC-3′
 aroFwt_R5′-ATCGACGAGCATATTCCAGA-3′
 pheA_F5′-AAGCCCTCTACAAATTTGCC-3′
 pheA_R5′-GTTGGAGCCCTGGTCAA-3′
 pheAfbr_F5′-GCGCTGGATGAAAAATTATT-3′
 pheAfbr_R5′-GCTTTACCGAGCGTAATTAA-3′
Primers and reverse transcription primersSequencea
Primers
 aroG-F5′-CTAGTCTAGAAAAGGAGGACACGCATGAGTTCTCCAGTCTCACTCGAAAA-3′
 aroG-R5′-TCCCCCGGGTTACTTGGCTGCTGCTCGGC-3′
 aroF-F5′-CCCAAGCTTAAAGGAGGACACGCATGAGTTCTCCAGTCTCACTCGAAAA-3′
 aroF-R5′-CGCGGATCCTTACTTGGCTGCTGCTCGGC-3′
 aroFwt-F5′-TCCCCGCGGAAAGGAGGACACGCATGCAAAAAGACGCGCTGAATAACG-3′
 aroFwt-R5′-CGCGGATCCCCGCTCGAGTTAAGCCACGCGAGCCGTCA-3′
 aroH-F5′-CGCGGATCCAAAGGAGGACACGCATGAACAGAACTGACGAACTCCGTAC-3′
 aroH-R5′-TCCCCCGGGCCGCTCGAGTCAGAAGCGGGTATCTACCGCA-3′
 pheA-F5′-CCCAAGCTTAAAGGAGGACACGC ATGAGCGACGCACCAACTGTTG-3′
 pheA-R5′-TCCCCCGGG CTAGTTAAGTTTCCTTCCTTCGCTTGCT-3′
 pheAfbr-F5′-CCCAAGCTTAAAGGAGGACACGCATGACATCGGAAAACCCGTTACT-3′
 pheAfbr-R5′-TGCACTGCAGTCCCCGCGGTCAGGTTGGATCAACAGGCACTA-3′
Primers for RT-PCR
 aroH_F5′-ACTGACGAACTCCGTACTGC-3′
 aroH_R5′-TCGCTTATCTTCACCATTCA-3′
 aroFwt_F5′-AGACGCGCTGAATAACGTAC-3′
 aroFwt_R5′-ATCGACGAGCATATTCCAGA-3′
 pheA_F5′-AAGCCCTCTACAAATTTGCC-3′
 pheA_R5′-GTTGGAGCCCTGGTCAA-3′
 pheAfbr_F5′-GCGCTGGATGAAAAATTATT-3′
 pheAfbr_R5′-GCTTTACCGAGCGTAATTAA-3′

RT reverse transcription

aUnderlining indicates restriction enzyme sites; bold indicates the location of the Shine-Dalgarno sequence added artificially

Primers used in this study

Primers and reverse transcription primersSequencea
Primers
 aroG-F5′-CTAGTCTAGAAAAGGAGGACACGCATGAGTTCTCCAGTCTCACTCGAAAA-3′
 aroG-R5′-TCCCCCGGGTTACTTGGCTGCTGCTCGGC-3′
 aroF-F5′-CCCAAGCTTAAAGGAGGACACGCATGAGTTCTCCAGTCTCACTCGAAAA-3′
 aroF-R5′-CGCGGATCCTTACTTGGCTGCTGCTCGGC-3′
 aroFwt-F5′-TCCCCGCGGAAAGGAGGACACGCATGCAAAAAGACGCGCTGAATAACG-3′
 aroFwt-R5′-CGCGGATCCCCGCTCGAGTTAAGCCACGCGAGCCGTCA-3′
 aroH-F5′-CGCGGATCCAAAGGAGGACACGCATGAACAGAACTGACGAACTCCGTAC-3′
 aroH-R5′-TCCCCCGGGCCGCTCGAGTCAGAAGCGGGTATCTACCGCA-3′
 pheA-F5′-CCCAAGCTTAAAGGAGGACACGC ATGAGCGACGCACCAACTGTTG-3′
 pheA-R5′-TCCCCCGGG CTAGTTAAGTTTCCTTCCTTCGCTTGCT-3′
 pheAfbr-F5′-CCCAAGCTTAAAGGAGGACACGCATGACATCGGAAAACCCGTTACT-3′
 pheAfbr-R5′-TGCACTGCAGTCCCCGCGGTCAGGTTGGATCAACAGGCACTA-3′
Primers for RT-PCR
 aroH_F5′-ACTGACGAACTCCGTACTGC-3′
 aroH_R5′-TCGCTTATCTTCACCATTCA-3′
 aroFwt_F5′-AGACGCGCTGAATAACGTAC-3′
 aroFwt_R5′-ATCGACGAGCATATTCCAGA-3′
 pheA_F5′-AAGCCCTCTACAAATTTGCC-3′
 pheA_R5′-GTTGGAGCCCTGGTCAA-3′
 pheAfbr_F5′-GCGCTGGATGAAAAATTATT-3′
 pheAfbr_R5′-GCTTTACCGAGCGTAATTAA-3′
Primers and reverse transcription primersSequencea
Primers
 aroG-F5′-CTAGTCTAGAAAAGGAGGACACGCATGAGTTCTCCAGTCTCACTCGAAAA-3′
 aroG-R5′-TCCCCCGGGTTACTTGGCTGCTGCTCGGC-3′
 aroF-F5′-CCCAAGCTTAAAGGAGGACACGCATGAGTTCTCCAGTCTCACTCGAAAA-3′
 aroF-R5′-CGCGGATCCTTACTTGGCTGCTGCTCGGC-3′
 aroFwt-F5′-TCCCCGCGGAAAGGAGGACACGCATGCAAAAAGACGCGCTGAATAACG-3′
 aroFwt-R5′-CGCGGATCCCCGCTCGAGTTAAGCCACGCGAGCCGTCA-3′
 aroH-F5′-CGCGGATCCAAAGGAGGACACGCATGAACAGAACTGACGAACTCCGTAC-3′
 aroH-R5′-TCCCCCGGGCCGCTCGAGTCAGAAGCGGGTATCTACCGCA-3′
 pheA-F5′-CCCAAGCTTAAAGGAGGACACGC ATGAGCGACGCACCAACTGTTG-3′
 pheA-R5′-TCCCCCGGG CTAGTTAAGTTTCCTTCCTTCGCTTGCT-3′
 pheAfbr-F5′-CCCAAGCTTAAAGGAGGACACGCATGACATCGGAAAACCCGTTACT-3′
 pheAfbr-R5′-TGCACTGCAGTCCCCGCGGTCAGGTTGGATCAACAGGCACTA-3′
Primers for RT-PCR
 aroH_F5′-ACTGACGAACTCCGTACTGC-3′
 aroH_R5′-TCGCTTATCTTCACCATTCA-3′
 aroFwt_F5′-AGACGCGCTGAATAACGTAC-3′
 aroFwt_R5′-ATCGACGAGCATATTCCAGA-3′
 pheA_F5′-AAGCCCTCTACAAATTTGCC-3′
 pheA_R5′-GTTGGAGCCCTGGTCAA-3′
 pheAfbr_F5′-GCGCTGGATGAAAAATTATT-3′
 pheAfbr_R5′-GCTTTACCGAGCGTAATTAA-3′

RT reverse transcription

aUnderlining indicates restriction enzyme sites; bold indicates the location of the Shine-Dalgarno sequence added artificially

Corynebacterium glutamicum transformation

Corynebacterium glutamicum competent cells for electroporation were prepared by the method described by Xu et al. [30]. Briefly, a colony of C. glutamicum was inoculated into 30 ml of LBG (LB medium with 5 g l−1 glucose) and cultivated overnight for about 16 h at 30 °C with agitation (200 rpm). The overnight cell culture was diluted into Epo medium (10 g l−1 tryptone, 5 g l−1 yeast extract, 10 g l−1 NaCl, 4 g l−1 isonicotinic acid hydrazide, 25 g l−1 glycine, 0.1 % Tween 80) to an optical density at 600 nm (OD600) of 0.3 and cultured at 200 rpm and 30 °C until the OD600 reached 0.9. The culture was then chilled on ice for 10 min, harvested by centrifugation (4,000 g, 10 min) and washed four times with 15 ml ice-cold 10 % (v/v) glycerol; the cells were re-suspended in 0.2 ml 10 % (v/v) glycerol, frozen and stored as aliquots at −70 °C. For electro-transformation, the aliquots of competent cells were first thawed on ice, and 1–5 μl DNA was added. The mixture was transferred to a cold electroporation cuvette (gap 0.1 cm) and electroporated at 1.8 kV using a 10-ms (approx.) pulse. Immediately after electroporation, 1 ml LBHIS media (5 g l−1 tryptone, 5 g l−1 NaCl, 2.5 g l−1 yeast extract, 18.5 g l−1 Brain Heart infusion powder, 91 g l−1 sorbitol) was added to the cuvette, and the contents were first mixed and then transferred to a 2-ml sterile Eppendorf tube. The mixture was then incubated at 30 °C for 2 h before being plated on LBHIS agar containing the appropriate antibiotics.

RNA extraction

Cells were harvested (2,000 g, 5 min) and washed twice with double distilled water and stored at −80 °C until RNA preparation. Total RNA from the untreated control and D-limonene-treated cells with and without exogenous ergosterol was extracted using Trizol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions. The RNA was quantified and checked in a Nanodrop ND-1000 spectrophotometer (Thermo Scientific, Wilmington, DE) at 260 and 280 nm. The integrity of the isolated RNA was verified using an automated electrophoresis system (Bio-Rad, Hercules, CA).

Culture conditions and medium

Corynebacterium glutamicum strains were grown at 30 °C in LBG medium. Where necessary, an antibiotic, such as ampicillin (100 μg ml−1), kanamycin (50 μg ml−1) or chloramphenicol (34 μg ml−1), was supplemented to the medium. A 10 % (v/v) inoculum of an overnight culture (18 h) was used for further studies. To induce the expression of the various genes carried by the plasmids, isopropyl-β-D-thiogalactopyranoside (IPTG) was added to a final concentration of 0.1 mM. Flask cultivations were carried out in 20 ml of medium in a 250-ml Erlenmeyer flask medium at 30 °C with agitation at 200 rpm.

The seed medium contained (g l−1) glucose (35), corn steep liquor (35), (NH4)2SO4 (5), urea (2), KH2PO4 (1), MgSO4·7H2O (0.5); the pH was 7.2. The shake flask fermentation medium contained (g l−1) glucose (90), (NH4)2SO4 (25), corn steep liquor (8), KH2PO4 (1), MgSO4 (0.5), CaCO3 (20); the pH was 7.2.

RT-PCR assay

cDNA was synthesized from 5 μg of total RNA using the Primescript ® RT Reagent Kit Perfect Real Time (Takara, Dalian, China), and the cDNA obtained was used as the template in the subsequent PCR assay. All primer sequences are given in Table 1. The efficiency and specificity of the primers were determined from dilution experiments and melting curves, respectively. RT-PCR experiments were performed using PrimeSTAR® HS DNA Polymerase (Takara), and the parameters for PCR cycling were: denaturation at 95 °C for 5 min, degeneration at 95 °C for 30 s, annealing at 65 °C for 30 s, extension at 72 °C for the associated time (1 kb min−1), final extension at 72 °C for 10 min, and heat preservation at 12 °C.

SDS-PAGE analysis

Analysis by SDS-PAGE was performed in 10 % acrylamide gels, and the proteins were visualized by staining with Coomassie brilliant blue R-250. About 1.0 OD600 of cell culture was obtained after 12 h of induction. Whole cells were harvested at 4,000 g for 10 min and then washed third times with double distilled water. The cells were then resuspended in 40 μl lysozyme (20 mM) and lysed at 37 °C for 1 h, following which 10 μl of the 5× loading buffer was added for the SDS-PAGE analysis.

Analysis of fermentation parameters

The cell concentration was measured at OD600 on a spectrophotometer-722 (Third Analytical Instrument Factory, Shanghai, China) after the appropriate dilution. To determine the concentration of intracellular metabolites, 5 ml of cell culture was rapidly transferred into a centrifuge tube containing 20 ml of precooled glycerol-NaCl (glycerol and 13.5 g l−1 NaCl solution; volume ratio 1:1) and the mixture centrifuged (10,000 g, 3 min, −19 °C). The cells were then resuspended in 1 ml of precooled 50 % methanol solution in a centrifuge tube and the centrifuge tube placed in liquid nitrogen for 2–3 min and then thawed on ice; the freezing–thawing procedures were repeated three times. The supernatant obtained after centrifugation was either directly analyzed by high-performance liquid chromatography (HPLC) to determine the concentration of metabolites or preserved at −80 °C. For shikimate analysis, 5 ml of cell culture was centrifuged (7,000 g, 10 min), and the supernatant filtered through a filtration membrane (diameter 25 mm; pore size 0.22 μm. The filtered sample was analyzed on an Agilent 1200 HPLC system (Agilent Technologies, Santa Clara, CA) which was equipped with a 250 × 4.6-mm ZORBAX SB-Aq column (Agilent Technologies), a standard G 1329A autosampler (Agilent Technologies) and a G13158 diode array detector (DAD) (Agilent Technologies). Na2HPO4 (0.138 mol l−1) and acetonitrile (1 %, v/v) adjusted to pH 2.0 with phosphoric acid were used as the mobile phase at a flow rate of 1.0 ml min−1. The detection wavelength was 210 nm, and the column temperature was maintained at 35 °C.

To determine the concentration of amino acids, 5 ml of cell culture or intracellular supernatant was centrifuged (10,000 g, 10 min) and the supernatant was diluted with trichloroacetic acid (5 g l−1) and filtered through a membrane (pore size 0.22 μm). Amino acids were precolumn derivatized by o-phthaldialdehyde (OPA) and then analyzed on an Agilent 1100 HPLC system (Agilent Technologies) equipped with a reverse-phase column (Zorbax Eclipse-AAA) and an UV detector at 338 nm according to the procedure established by Henderson et al. [11].

Results

Single overexpression of the committed enzymes driving more flux to l-Phe

In C. glutamicum, the synthesis of l-Phe occurs via the shikimate pathway and the branch acid pathway. To evaluate the rate-limiting steps of the l-Phe synthesis pathways, we first examined the committed genes aroG, aroF, pheA, aroFwt and pheAfbr (Table 1). As shown in Table 3, under specific conditions, strains C. glutamicum ATCC 13032, C. glutamicum 19G (aroG), C. glutamicum 19F (aroF), C. glutamicum 19Fwt (aroFwt), C. glutamicum 19A (pheA) and C. glutamicum 19Afbr (pheAfbr) accumulated l-Phe to levels of 0.34 ± 0.03, 0.43 ± 0.01, 0.56 ± 0.06, 0.88 ± 0.06, 0.27 ± 0.06 and 1.34 ± 0.02 g l−1, respectively. Clearly, single overexpression of the mutated gene aroFwt or pheAfbr significantly improved l-Phe production. Compared with l-Phe, l-Tyr as the end byproduct was not increased by the upregulation of aroFwt or pheAfbr; to the contrary, single overexpression of pheAfbr resulted in a decrease of l-Tyr accumulation (Table 3), indicating that more carbon flux was driven to l-Phe.

Comparison of l-phenylalanine, l-tyrosine and shikimate production in different strains

Strainsl-Phe (g l−1)l-Tyr (g l−1)Shikimate (g l−1)
C. glutamicum ATCC 130320.34 ± 0.030.260 ± 0.020.29 ± 0.08
C. glutamicum 19G0.43 ± 0.010.06 ± 0.050.69 ± 0.07
C. glutamicum 19F0.56 ± 0.060.37 ± 0.041.54 ± 0.04
C. glutamicum 19Fwt0.88 ± 0.060.27 ± 0.015.67 ± 0.05
C. glutamicum 19A0.27 ± 0.060.32 ± 0.020.32 ± 0.04
C. glutamicum 19Afbr1.34 ± 0.020.04 ± 0.070.28 ± 0.05
Strainsl-Phe (g l−1)l-Tyr (g l−1)Shikimate (g l−1)
C. glutamicum ATCC 130320.34 ± 0.030.260 ± 0.020.29 ± 0.08
C. glutamicum 19G0.43 ± 0.010.06 ± 0.050.69 ± 0.07
C. glutamicum 19F0.56 ± 0.060.37 ± 0.041.54 ± 0.04
C. glutamicum 19Fwt0.88 ± 0.060.27 ± 0.015.67 ± 0.05
C. glutamicum 19A0.27 ± 0.060.32 ± 0.020.32 ± 0.04
C. glutamicum 19Afbr1.34 ± 0.020.04 ± 0.070.28 ± 0.05

l-Phe  l-phenylalanine, l-Tyr  l-tyrosine

Data are presented as the mean ± standard deviation (SD) (n = 3)

Comparison of l-phenylalanine, l-tyrosine and shikimate production in different strains

Strainsl-Phe (g l−1)l-Tyr (g l−1)Shikimate (g l−1)
C. glutamicum ATCC 130320.34 ± 0.030.260 ± 0.020.29 ± 0.08
C. glutamicum 19G0.43 ± 0.010.06 ± 0.050.69 ± 0.07
C. glutamicum 19F0.56 ± 0.060.37 ± 0.041.54 ± 0.04
C. glutamicum 19Fwt0.88 ± 0.060.27 ± 0.015.67 ± 0.05
C. glutamicum 19A0.27 ± 0.060.32 ± 0.020.32 ± 0.04
C. glutamicum 19Afbr1.34 ± 0.020.04 ± 0.070.28 ± 0.05
Strainsl-Phe (g l−1)l-Tyr (g l−1)Shikimate (g l−1)
C. glutamicum ATCC 130320.34 ± 0.030.260 ± 0.020.29 ± 0.08
C. glutamicum 19G0.43 ± 0.010.06 ± 0.050.69 ± 0.07
C. glutamicum 19F0.56 ± 0.060.37 ± 0.041.54 ± 0.04
C. glutamicum 19Fwt0.88 ± 0.060.27 ± 0.015.67 ± 0.05
C. glutamicum 19A0.27 ± 0.060.32 ± 0.020.32 ± 0.04
C. glutamicum 19Afbr1.34 ± 0.020.04 ± 0.070.28 ± 0.05

l-Phe  l-phenylalanine, l-Tyr  l-tyrosine

Data are presented as the mean ± standard deviation (SD) (n = 3)

To investigate the effect of disturbance by single overexpression of the above-mentioned genes, shikimate as the committed intermediate was also analyzed. As shown in Table 3, upregulation of the upstream genes aroG, aroF or aroFwt could lead to an apparent accumulation of shikimate which was consistent with the accumulation of l-Phe. Specially, the recombinant C. glutamicum 19Fwt (aroFwt) increased shikimate accumulation to 5.67 ± 0.05 g l−1, suggesting that other key genes must be involved downstream of the aromatic amino acid synthesis. In addition, no l-Trp was detected throughout the cultivation process.

Introduction of the wild-type aroH gene for improving l-Phe production

By comparing the shikimate pathway (Fig. 1), we found that in E. coli, the DS enzyme is encoded by three genes (aroG, aroF and aroH). However, in C. glutamicum, it is encoded by only two genes, namely, aroG and aroF. This difference led us to hypothesize that heterogenous overexpression of the wild-type aroH gene in C. glutamicum should be active because of the natural strict regulation of the l-Trp branch pathway. As expected, introduction of the wild-type aroH gene increased l-Phe, l-Tyr and shikimate accumulation to 0.99 ± 0.06, 0.44 ± 0.02 and 6.80 ± 0.09 g l−1, respectively (Fig. 2). Furthermore, no detectable l-Trp was accumulated during cultivation. To demonstrate the high levels of l-Phe that accumulated, we added l-Trp into the culture to study its effect on l-Phe accumulation. As shown in Fig. 2, the addition of 1 g l−1  l-Trp dramatically decreased l-Phe and shikimate accumulation to 0.44 ± 0.06 and 1.24 ± 0.08 g l−1, respectively. At the same time, the l-Tyr level also decreased from 0.44 ± 0.02 to 0.31 ± 0.04 g l−1. When the intracellular concentrations of l-Phe, l-Trp and l-Tyr were assayed, we found that l-Phe, l-Trp and l-Tyr had been maintained at milligram levels without any obvious change (data not shown), suggesting that majority of aromatic amino acids were secreted extracellular.
Fig. 2

Accumulation of metabolites by the recombinant C. glutamicum 19H (aroH from E. coli) in the absence of l-tryptophan (l-Trp) (a) and following the addition of 1.0 g l−1  l-Trp to the culture (b). Data are presented as the mean ± standard deviation (SD) (n = 3)

Production of l-Phe by overexpression of aroH and pheAfbr

Based on these results, we constructed and comparatively investigated the recombinant C. glutamicum 19AfbrH (pheAfbr, aroH) and C. glutamicum 19AfbrFwt (pheAfbr, aroFwt). As shown in Fig. 3, Co-overexpression of pheAfbr and aroH resulted in a substantial increase in l-Phe (4.64 ± 0.09 g l−1) accumulation and a remarkable decline of shikimate (3.2 ± 0.05 g l−1), which confirmed the important role of the mutated pheAfbr. Correspondingly, C. glutamicum 19AfbrFwt accumulated l-Phe and shikimate up to levels of 4.46 ± 0.06 and 2.89 ± 0.06 g l−1, respectively. By comparison, we found that co-overexpression of pheAfbr and aroH, or of pheAfbr and aroFwt had no effect on l-Tyr accumulation, which further demonstrated that a large proportion of the carbon source was directed to l-Phe. Furthermore, l-Trp was still not detectable during the whole cultivation process.
Fig. 3

Accumulation of metabolites by co-overexpression of pheAfbr and aroFwt, and pheAfbr and aroH. a The recombinant C. glutamicum 19AfbrH, b the recombinant C. glutamicum 19AfbrFwt. Data are presented as the mean ± SD (n = 3)

To characterize the pathway we had engineered, we studied the expression levels of the key enzymes. At the transcriptional level, all of the committed genes pheA, pheAfbr, aroH, aroF and aroFwt investigated were successfully transcribed (Fig. 4a); this result is consistent with our cultivation results. However, an unbalanced expression level was observed by SDS-PAGE analysis. When the aroFwt, aroH, pheA and pheAfbr genes were individually overexpressed, a distinct band of each enzyme was detected (Fig. 4b). However, when pheAfbr and aroH or pheAfbr and aroFwt were co-overexpressed within one operon, no distinct bands of AroH and AroF were detected (Fig. 4b).
Fig. 4

Analysis of the transcript level of key enzymes in recombinant C. glutamicum by reverse transcription (RT)-PCR and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with Coomassie brilliant blue staining of protein products. a RT-PCR. Lanes: M DL 500 DNA ladder, 1 control (pheA), 2 C. glutamicum 19A (pheA), 3 control (aroH), 4 C. glutamicum 19H (aroH), 5 C. glutamicum 19AfbrH (aroH), 6 C. glutamicum 19Afbr (pheAfbr), 7 C. glutamicum 19AfbrH (pheAfbr), 8 control (pheAfbr), 9 C. glutamicum 19Afbr (pheAfbr), 10 C. glutamicum 19AfbrFwt (pheAfbr), 11 C. glutamicum 19Fwt (aroFwt), 12 C. glutamicum 19AfbrFwt (aroFwt). b SDS-PAGE. Lanes 1 C. glutamicum ATCC 13032, 2 C. glutamicum 19Fwt, 3 C. glutamicum 19H, 4 C. glutamicum 19A, 5 C. glutamicum 19Afbr, 6 C. glutamicum 19AfbrFwt, 7 C. glutamicum AfbrH, M molecular weight marker

Discussion

In nature, the biosynthetic pathway of amino acids is strictly regulated (generally by feedback inhibition) in C. glutamicum. As a result, modification of the committed enzymes to relieve or eliminate the feedback inhibition by the end-products is crucial to increasing the target compound [29, 32]. In this study, the wild-type aroH gene from E. coli was cloned into C. glutamicum to optimize the shikimate pathway for producing l-Phe.

Many studies have been carried out in E. coli, resulting in a substantial improvement in the production of l-Phe [1, 8, 13, 33]. When we first investigated the committed genes involved in l-Phe production, we found that single overexpression of the native wild-type aroG, aroF and pheA genes had no obvious effect on the yield of l-Phe (Table 3), further demonstrating that the synthesis of l-Phe in C. glutamicum is extremely tightly regulated. To the contrary, when either the mutated aroFwt (E. coli) or pheAfbr (E. coli) gene was introduced into C. glutamicum, the titer of l-Phe was dramatically increased (Table 3), indicating that feedback inhibition to DS (encoded by aroFwt) or CM-PDT [12] (encoded by pheAfbr) had occurred. Subsequent studies on the overexpression of the mutated aroFwt from E. coli in C. glutamicum revealed that shikimate was increased up to a high level (Table 3), demonstrating that other key enzymes are present in downstream of the pathway.

In E. coli, the DS enzyme encoded by aroH is inhibited by feedback from l-Trp, contributing 1 % to DS enzyme activity [13, 27]. In contrast, no aroH gene is naturally present in C. glutamicum, and thus the introduction and overexpression of the wild-type aroH gene from E. coli may be beneficial to the production of l-Phe by C. glutamicum. As expected, introduction of aroH achieved a substantial increase in l-Phe production without l-Trp accumulation, thereby demonstrating the complete inhibition of the native branch pathway for l-Trp synthesis (Fig. 1). The capacity of the aroH gene and the strategy of co-overexpression of the committed enzymes have been studied [19, 29, 32, 33]. As predicted, we found that co-overexpression of the rate-limiting enzymes DS and CM-PDT yielded a high titer of l-Phe (Fig. 3). Moreover, compared with C. glutamicum 19AfbrFwt, C. glutamicum 19AfbrH showed the better property, which revealed that although aroF was mutated, the release of feedback inhibition may be incomplete in vivo. To modulate and balance the pathway flux, we also investigated the expression levels of the key genes at the transcriptional and translational levels, respectively. At the transcriptional level, all of the genes studied were successfully transcribed (Fig. 4a). However, an unbalanced expression level was observed in the SDS-PAGE analysis. When two genes were co-expressed with one operon, the expression level of the gene further away from the promoter declined sharply and no obvious band was detected (Fig. 4b). Similar results have been reported in E. coli [19]. Consequently, to further increase the titer of the targeted product, subtle regulation of the committed genes might be crucial [5, 28].

In conclusion, for a comparative analysis of the committed enzymes involved in the aromatic amino acid synthesis pathway in C. glutamicum and E. coli, we used the wild-type gene aroH from E. coli for improving l-Phe production. As predicted, the introduction and overexpression of this gene in C. glutamicum remarkably increased l-Phe production by C. glutamicum. Compared with aroFwt, the aroH gene from E. coli was shown to be more effective for l-Phe production. Moreover, the observed unbalanced expression levels of the genes within one operon suggested that fine control of the committed enzymes will be very important for improving l-Phe production. The knowledge gained through this study will provide further insights into novel pathway engineering of C. glutamicum for l-Phe production.

Acknowledgments

We thank Professor Byong Lee at Jiangnan University for his discussion and revision. This work was financially supported by the Key Program of National Natural Science Foundation of China (31130043), the National Natural Science Foundation of China (31200020, 31000054, 31171638), the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Jiangsu Planned Projects for Postdoctoral Research Funds (1101053C) and the Independent Innovation Program of Jiangnan University (JUSRP111A23).

References

1.

Baez-Viveros
JL
,
Osuna
J
,
Hernandez Chavez
G
,
Soberon
X
,
Bolivar
F
,
Gosset
G
Metabolic engineering and protein directed evolution increase the yield of l-phenylalanine synthesized from glucose in Escherichia coli
 
Biotechnol Bioeng
 
2004
 
87
 
516
 
524
 

2.

Becker
J
,
Wittmann
C
Bio-based production of chemicals, materials and fuels–Corynebacterium glutamicum as versatile cell factory
 
Curr Opin Microbiol
 
2012
 
23
 
631
 
640

3.

Date
M
,
Itaya
H
,
Matsui
H
,
Kikuchi
Y
Secretion of human epidermal growth factor by Corynebacterium glutamicum
 
Lett Appl Microbiol
 
2006
 
42
 
66
 
70
 

4.

Date
M
,
Yokoyama
K
,
Umezawa
Y
,
Matsui
H
,
Kikuchi
Y
Production of native-type Streptoverticillium mobaraense transglutaminase in Corynebacterium glutamicum
 
Appl Environ Microbiol
 
2003
 
69
 
3011
 
3014
 

5.

Dueber
JE
,
Wu
GC
,
Malmirchegini
GR
,
Moon
TS
,
Petzold
CJ
,
Ullal
AV
,
Prather
KL
,
Keasling
JD
Synthetic protein scaffolds provide modular control over metabolic flux
 
Nat Biotechnol
 
2009
 
27
 
753
 
759
 

6.

Eggeling L, Bott M (2005) Handbook of Corynebacterium glutamicum. CRC Press, Baton Rouge

7.

Gelfand
DH
,
Steinberg
RA
Escherichia coli mutants deficient in the aspartate and aromatic amino acid aminotransferases
 
J Bacteriol
 
1977
 
130
 
429
 
440

8.

Gerigk
MR
,
Maass
D
,
Kreutzer
A
,
Sprenger
G
,
Bongaerts
J
,
Wubbolts
M
,
Takors
R
Enhanced pilot-scale fed-batch l-phenylalanine production with recombinant Escherichia coli by fully integrated reactive extraction
 
Bioprocess Biosyst Eng
 
2002
 
25
 
43
 
52
 

9.

Gopinath
V
,
Murali
A
,
Dhar
KS
,
Nampoothiri
KM
Corynebacterium glutamicum as a potent biocatalyst for the bioconversion of pentose sugars to value-added products
 
Appl Microbiol Biotechnol
 
2012
 
93
 
95
 
106
 

10.

Gu
P
,
Yang
F
,
Kang
J
,
Wang
Q
,
Qi
Q
One-step of tryptophan attenuator inactivation and promoter swapping to improve the production of l-tryptophan in Escherichia coli
 
Microb Cell Fact
 
2012
 
11
 
30
 
38
 

11.

Henderson JW, Ricker RD, Bidlingmeyer BA et al (2000) Rapid, accurate, sensitive, and reproducible HPLC analysis of amino acids. USA (Agilent App Note 5980–1193E). Agilent Technologies, Santa Clara

12.

Hsu
SK
,
Lin
LL
,
Lo
HH
,
Hsu
WH
Mutational analysis of feedback inhibition and catalytic sites of prephenate dehydratase from Corynebacterium glutamicum
 
Arch Microbiol
 
2004
 
181
 
237
 
244
 

13.

Hu
C
,
Jiang
P
,
Xu
J
,
Wu
J
,
Huang
W
Mutation analysis of the feedback inhibition site of phenylalanine-sensitive 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase of Escherichia coli
 
J Basic Microbiol
 
2003
 
43
 
399
 
406
 

14.

Hudson
GS
,
Davidson
BE
Nucleotide sequence and transcription of the phenylalanine and tyrosine operons of Escherichia coli K12
 
J Mol Biol
 
1984
 
180
 
1023
 
1051
 

15.

Ikeda
M
Towards bacterial strains overproducing l-tryptophan and other aromatics by metabolic engineering
 
Appl Microbiol Biotechnol
 
2006
 
69
 
615
 
626
 

16.

Ikeda
M
,
Katsumata
R
Metabolic engineering to produce tyrosine or thenylalanine in a tryptophan-producing Corynebacterium glutamicum Strain
 
Appl Environ Microbiol
 
1992
 
58
 
781
 
785

17.

Ikeda
M
,
Ozaki
A
,
Katsumata
R
Phenylalanine production by metabolically engineered Corynebacterium glutamicum with the pheA gene of Escherichia coli
 
Appl Microbiol Biotechnol
 
1993
 
39
 
318
 
323
 

18.

Jakoby
M
,
Ngouoto-Nkili
CE
,
Burkovski
A
Construction and application of new Corynebacterium glutamicum vectors
 
Biotechnol Technol
 
1999
 
13
 
437
 
441
 

19.

Juminaga
D
,
Baidoo
EEK
,
Redding-Johanson
AM
,
Batth
TS
,
Burd
H
,
Mukhopadhyay
A
,
Petzold
CJ
,
Keasling
JD
Modular Engineering of l-Tyrosine Production in Escherichia coli
 
Appl Environ Microbiol
 
2011
 
78
 
89
 
98
 

20.

Kikuchi
Y
,
Date
M
,
Yokoyama
K
,
Umezawa
Y
,
Matsui
H
Secretion of active-form Streptoverticillium mobaraense transglutaminase by Corynebacterium glutamicum: processing of the pro-transglutaminase by a cosecreted subtilisin-like protease from Streptomyces albogriseolus
 
Appl Environ Microbiol
 
2003
 
69
 
358
 
366
 

21.

Li
PP
,
Liu
YJ
,
Liu
SHJ
Genetic and biochemical identification of the chorismate mutase from Corynebacterium glutamicum
 
Microbiology
 
2009
 
155
 
3382
 
3391
 

22.

Liu
DX
,
Fan
CS
,
Tao
JH
,
Liang
GX
,
Gao
SE
,
Wang
HJ
,
Li
X
,
Song
DX
Integration of E. coli aroG-pheA tandem genes into Corynebacterium glutamicum tyrA locus and its effect on l-phenylalanine biosynthesis
 
World J Gastroenterol
 
2004
 
10
 
3683
 
3687

23.

Nešvera
J
,
Pátek
M
Tools for genetic manipulations in Corynebacterium glutamicum and their applications
 
Appl Microbiol Biotechnol
 
2011
 
90
 
1641
 
1654
 

24.

Shu
CH
,
Liao
CC
Optimization of l-phenylalanine production of Corynebacterium glutamicum under product feedback inhibition by elevated oxygen transfer rate
 
Biotechnol Bioeng
 
2002
 
77
 
131
 
141
 

25.

Sprenger
G
Wendisch
VF
Aromatic amino acids
 
Amino acid biosynthesis pathways regulation and metabolic engineering
 
2007
 
Berlin
 
Springer
 
93
 
127

26.

Takors
R
,
Bathe
B
,
Rieping
M
,
Hans
S
,
Kelle
R
,
Huthmacher
K
Systems biology for industrial strains and fermentation processes-example: amino acids
 
J Biotechnol
 
2007
 
129
 
181
 
190
 

27.

Tribe
D
,
Camakaris
H
,
Pittard
J
Constitutive and repressivle enzymes of the common pathway of aromatic biosynthesis in Escherichia coli K-12: regulation of enzyme synthesis at different growth rates
 
J Bacteriol
 
1976
 
127
 
1085

28.

Tyo
KE
,
Kocharin
K
,
Nielsen
J
Toward design-based engineering of industrial microbes
 
Curr Opin Microbiol
 
2010
 
13
 
255
 
262
 

29.

Wu
YQ
,
Jiang
PH
,
Fan
CS
,
Wang
JG
,
Shang
L
,
Huang
WD
Co-expression of five genes in E. coli or l-phenylalanine in Brevibacterium flavum
 
World J Gastroentero
 
2003
 
9
 
342
 
346

30.

Xu
DQ
,
Tan
YZ
,
Huan
XJ
,
Hu
XQ
,
Wang
XY
Construction of a novel shuttle vector for use in Brevibacterium flavum, an industrial amino acid producer
 
J Microbiol Method
 
2010
 
80
 
86
 
92
 

31.

Yakandawala
N
,
Romeo
T
,
Friesen
AD
,
Madhyastha
S
Metabolic engineering of Escherichia coli to enhance phenylalanine production
 
Appl Microbiol Biotechnol
 
2008
 
78
 
283
 
291
 

32.

Yin
L
,
Hu
X
,
Xu
D
,
Ning
J
,
Chen
J
,
Wang
X
Co-expression of feedback-resistant threonine dehydratase and acetohydroxy acid synthase increase l-isoleucine production in Corynebacterium glutamicum
 
Metab Eng
 
2012
 
14
 
542
 
550
 

33.

Zhou
H
,
Liao
X
,
Wang
T
,
Du
G
,
Chen
J
Enhanced l-phenylalanine biosynthesis by co-expression of pheAfbr and aroFwt
 
Bioresour Technol
 
2010
 
101
 
4151
 
4156
 

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)